1242例受血患者输血前相关病原标志物检测结果分析

Analysis of test results about related pathogenic markers before transfusion in 1242 cases of blood recipients

目的:对受血患者进行输血前相关病原学标志物的检测,了解患者输血前状况,预防临床输血引起的医疗纠纷。方法:用酶联免疫吸附试验技术(ELISA)对1242例受血患者进行乙肝病毒标志物以及艾滋病(HIV)抗体、丙型肝炎(HCV)抗体检测;用甲苯胺红不加热血清反应素试验对梅毒进行检测。结果:1242例受血患者HBsAg阳性率为10.15%;HBcAb(IgG)阳性率为10.15%;HBeAg阳性率为2.90%;HBeAb阳性率为6.28%;HCV抗体阳性率为0.97%;HIV抗体阳性率为0%;梅毒阳性率为0.32%。结论:HIV、病毒性肝炎及梅毒等感染途径多种多样,判断是否由输血所致,必须对受血患者进行输血前相关病原学标志物的检测,及时发现阳性患者,否则感染来源难以界定,极易造成医疗纠纷。

Objective：To detect related pathogenic markers before transfusion in Order to find out the situation of blood recipients before transfusion and prevent medical disputes caused by clinical blood transfusion. Method： The blood markers of hepatitis B virus , HIV and HCV antibodies were detected by ELISA. The syphilis in 1 242 blood recipients were detected by toluidine red unheated serum test （TRUST）. Result： HBsAg＇s positive rate was 10.15 %, HBcAb（IgG）＇s positive rate was 10.15%, HBeAgs positive rate was 2.90 %, HBeAb＇s positive rate was 6.28%, HCV antibody＇s positive rate was 0.97%, HIV antibody＇s positive rate was 0%, and syphilis＇ positive rate was 0.32%. Conclusion：Routes of infection about AIDS, virus hepatitis and syphilis are varied. In order to judge whether caused by transfusion, we should detect related pathogenic markers before transfusion to discover the positive patients promptly. Otherwise it is hard to define infectious origin, and is extremely easy to cause the medical dispute.